I help pharmaceutical teams get materials approved faster — with fewer review cycles, clearer rationale, and zero PMCPA surprises.
Every failed review cycle means delayed launches, frustrated teams, and mounting risk. Most pharmaceutical companies don't have a shortage of good content — they have a shortage of consistent, confident compliance judgement.
That's where I come in. With 26 years of pharmaceutical leadership — including roles as a GMC-registered physician, ABPI Final Medical Signatory, and FFPM — I help teams build the knowledge and processes to get it right first time.
From one-off signatory cover to full team transformation — choose the support that fits your situation.
12 weeks of signatory-led coaching that transforms how your team reviews and approves materials. Built around real PMCPA cases and your actual challenges.
Learn more ↗Half-day and full-day sessions using your actual materials. Covers meetings, congresses, advisory boards, digital campaigns, and press releases.
Learn more ↗On-demand signatory coverage with same-day or next-day turnaround. Clear rationale, practical edits, flexible delivery — embedded or outsourced.
Learn more ↗Approval process design including SOPs, templates, and review workflows that reduce grey areas, speed up sign-off, and stand up to audit.
Learn more ↗Independent accuracy and reference verification. Data consistency checks, claim support validation, evidence logic review, and balance assessment.
Learn more ↗Senior-level compliance counsel for launches, audits, and complex regulatory situations. Strategic input when the stakes are highest.
Learn more ↗AskAnzal AI gives pharmaceutical professionals instant access to 13 specialist compliance advisors, each trained on the ABPI Code 2024, MHRA guidance, EFPIA, and IPHA.
Real rulings. Practical lessons. Published every day.
Gilead ruled in breach for failing to comply with an undertaking: Biktarvy tolerability claim remained on website
Allergan: Botox pack shots and award reposts on Instagram found to promote a POM to the public
AUTH/3285/12/19: Ex-employee v Daiichi-Sankyo – Underreporting transfers of value on Disclosure UK
Colonis voluntary admission: wrong prescribing information in promotional letter for Melatonin Oral Solution
GSK breach upheld on taskforce website: sponsorship not clearly acknowledged “from the outset” (Clause 25.3)
In-depth analysis of the issues that matter to compliance leads.
19 Feb 2026 · 9 min read
AI tools can enhance Medical affairs MLR workflows but pose governance challenges. It’s crucial to…
Read ↗12 Feb 2026 · 10 min read
TL;DR: Even a globally reputable company using trusted partners can stumble into serious compliance breaches…
Read ↗12 Feb 2026 · 2 min read
What 214 Social Media cases taught me about compliance risk I’ve just finished reviewing 214…
Read ↗"Anzal's mentorship programme completely changed how our team approaches materials review. We went from 4-5 review cycles to 1-2. The ROI was immediate."
"The workshop was unlike anything we'd done before — Anzal used our own materials and showed us exactly where the risks were. Incredibly practical and immediately applicable."
"Having Anzal as our on-demand signatory gave us the capacity we needed during a critical launch period. Fast, thorough, and always commercially aware."
Book a free 30-minute call to discuss your team's compliance challenges. No obligation — just straight answers from someone who's been on both sides of the sign-off table.
One real case. One key lesson. Every week — free.
